Epilepsy Research
Volume 30, Issue 1 , Pages 41-48 , March 1998

Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid

  • Matthias Radatz

      Affiliations

    • Department of Food Toxicology, School of Veterinary Medicine, Bischofsholer Damm 15, D30173, Hannover, Germany
    • ,
  • Katharine Ehlers

      Affiliations

    • Institute for Experimental Toxicology, Schering AG, Muellerstr. 170–178, D13342, Berlin, Germany
    • ,
  • Boris Yagen

      Affiliations

    • Department of Natural Products, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem, 91120, Israel
    • ,
  • Meir Bialer

      Affiliations

    • Department of Pharmaceutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, POB 12065, Jerusalem, 91120, Israel
    • ,
  • Heinz Nau

      Affiliations

    • Department of Food Toxicology, School of Veterinary Medicine, Bischofsholer Damm 15, D30173, Hannover, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 511 8567600; fax: +49 511 8567680; e-mail: hnau@lebensmittel.tiho-hannover.de

Received 25 July 1997 ,Revised 10 October 1997 ,Accepted 20 October 1997.

References 

  1. Abbott FS, Acheampong AA. Quantitative structure-anticonvulsant activity relationships of valproic acid, related carboxylic acids and tetrazoles. Neuropharmacology. 1988;27:287–294
  2. Barel S, Yagen B, Schurig V, Soback S, Pisani F, Perucca E, et al. Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and epileptic patients. Clin. Pharmacol. Ther. 1997;61:442–449
  3. Bialer M. Clinical pharmacology of valpromide. Clin. Pharmacokinet. 1991;20:1–9
  4. Bialer M, Haj-Yehia A, Barzaghi N, Pisani F, Perucca E. Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects. Eur. J. Pharmacol. 1990;38:289–291
  5. Binek J, Hany A, Egloff B, Heer M. Akute tödliche Leberinsuffizienz unter Valproinsäuretherapie. Schweiz Med. Wochenschr. 1991;121:228–233
  6. Bjerkedal, T., Czeizel, A., Goujard, J., Kallen, B., Mastroiacova, P., Nevin, N., Oakley, G., Robert, E., 1982. Valproic acid and spina bifida. Lancet II, 1096.
  7. Blotnik S, Bergman F, Bialer M. Dispositon of valpromide, valproic acid and valnoctamide in the brain, liver, plasma, and urine of rats. Drug Metab. Disposit. 1996;24:560–564
  8. Bojic U, Elmazar MMA, Hauck R-S, Nau H. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect. Chem. Res. Toxicol. 1996;9:866–870
  9. Bolton, S., 1984. Pharmaceutical Statistics. Marcel Dekker, New York, 133–135, 147–152.
  10. Chambon JP, Perio A. Valnoctamide: pharmacological data suggesting an antiepileptic activity. Neurosci. Lett. 1980;5:S327
  11. Ehlers K, Stürje H, Merker H-J, Nau H. Valproic acid-induced spina bifida: a mouse model. Teratology. 1992;45:145–154
  12. Elmazar MMA, Hauck R-S, Nau H. Anticonvulsant and neurotoxic activities of twelve analogues of valproic acid. J. Pharm. Sci. 1993;82:1255–1258
  13. Fisher E, Wittfoth W, Nau H. Quantitative determination of valproic acid and 14 metabolites in serum and urine by gas chromatography/mass spectrometry. Biomed. Chromatogr. 1992;6:24–29
  14. Haj-Yehia A, Bialer M. Pharmacokinetics of a valpromide isomer, valnoctamide, in dogs. J. Pharm. Sci. 1988;77:831–834
  15. Haj-Yehia A, Bialer M. Structure–pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity. Pharm. Res. 1989;8:683–689
  16. Haj-Yehia A, Bialer M. Structure–pharmacokinetic relationships in a series of short fatty acid amides that possess anticonvulsant activity. J. Pharm. Sci. 1990;79:719–724
  17. Hauck RS, Nau H. Zu den strukturellen Grundlagen der teratogenen Wirkung des Antiepileptikums Valproinsäure (VPA). Naturwissenschaften. 1989;76:528–529
  18. Hauck R-S, Nau H. Asymmetric synthesis and enantioselective teratogenicity of 2-n-propyl-4-pentenoic acid (4-en-VPA), an active metabolite of the anticonvulsant drug, valproic acid. Toxicol. Lett. 1989;49:41–48
  19. Jaeger-Roman E, Deichl A, Jakob S, Hartmann A-M, Koch S, Rating D, et al. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J. Pediat. 1986;108:997–1004
  20. Kao J, Brown NA, Schmid B, Goulding EH, Fabro S. Teratogenicity of valproic acid: in vivo and in vitro investigations. Teratogen Carcin Mut. 1981;1:367–382
  21. Keane PE, Simiand J, Mendes E, Santucci V, Morre M. The effects of analogues of valproic acid on seizures induced by pentylenetetrazol and GABA content in brain of mice. Neuropharmacology. 1983;22:875–879
  22. Levy, R.H., 1984. Valproate, modern perspectives. Epilepsia (Suppl. 1), 25.
  23. Lindhout, D., Meinardi, H., 1984. Spina bifida and in utero exposure to valproate. Lancet II, 396.
  24. Löscher W, Nau H. Pharmacological evaluation of various metabolites and analogues of vaproic acid. Neuropharmacology. 1985;24:427–435
  25. Menegola E, Broccia ML, Nau H, Prati M, Ricolfi R, Giavini E. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. Teratogen Carcinogen Mutagen. 1996;16:97–108
  26. Musolino R, Gallitto G, Morgante L, Pisani F, Nistico G, Di Perri R. Depamide: a preliminary report in its therapeutic efficacy in epilepsy. Monogr. Neural. Sci. 1980;5:124–130
  27. Nau H. Teratogenic valproic acid concentrations: infusion by implanted minipumps vs. conventional injection regimen in the mouse. Toxicol. Appl. Pharmacol. 1985;80:243–250
  28. Nau H. Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: correlation with neural tube defect formation in the mouse. Teratology. 1986;33:21–27
  29. Nau H. Species differences in pharmacokinetics and drug teratogenesis. Environ. Health Persp. 1986;70:113–129
  30. Nau H. Valproic acid teratogenicity in mice after various administration and phenobarbital-pretreatment regimens: the parent drug and not one of the metabolites assayed is implicated as teratogen. Fundam. Appl. Toxicol. 1986;6:662–668
  31. Nau H, Löscher W. Pharmacologic evaluation of various metabolites and analogs of valproic acid: teratogenic potencies in mice. Fundam. Appl. Toxicol. 1986;6:669–676
  32. Nau H, Scott WJ. Weak acids may act as teratogens by accumulating in the basic milieu of the eary mammalian embryo. Nature (London). 1986;323:276–278
  33. Nau H, Hendrickx AG. Valproic acid teratogenesis. ISI Atlas Sci. Pharmacol. 1987;1:52–56
  34. Nau H, Scott WJ. Teratogenicity of valproic acid and related subtances in the mouse: drug accumulation and pHi in the embryo during organogenesis and structure–activity considerations. Arch. Toxicol. 1987;11(Suppl.):128–139
  35. Nau H, Zierer R, Gansau Ch, Neubert D, Spielmann H. A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations. Life Sci. 1981;29:2803–2814
  36. Nau H, Löscher W, Schäfer H. Anticonvulsant activity and embryotoxicity of valproic acid. Neurology. 1984;34:400–401
  37. Nau H, Hauck R-S, Ehlers K. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms. Pharmacol. Toxicol. 1991;69:310–321
  38. Omzigt JGC, Nau H, Los FJ, Pijpers L, Lindhout D. The disposition of valproate and its metabolites in the late first trimester and the early second trimester of pregnancy in maternal serum, urine and amniotic fluid: effect of dose, comedication and the presence of spina bifida. Eur. J. Clin. Pharmacol. 1992;43:381–388
  39. Robert, E., Guibaud, P., 1982. Maternal valproic acid and congenital neural tube defects. Lancet II, 937.
  40. Robert, E., Rosa, F., 1983. Valproate and birth defects. Lancet II, 1142.
  41. Swinyard EA, Kupferberg HJ. Antiepileptic drugs: detection, quantification, and evaluation. Federation Proc. 1985;44:2629–2633

PII: S0920-1211(97)00095-8

Epilepsy Research
Volume 30, Issue 1 , Pages 41-48 , March 1998

Article Tools

* Image Usage & Resolution